Viewing Study NCT04661787



Ignite Creation Date: 2024-05-06 @ 3:32 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04661787
Status: RECRUITING
Last Update Posted: 2022-11-28
First Post: 2020-10-30

Brief Title: Donation Advisor Clinical Decision Support Tool Study
Sponsor: Ottawa Hospital Research Institute
Organization: Ottawa Hospital Research Institute

Study Overview

Official Title: Implementation of Donation Advisor a Personalized Clinical Decision Support Tool for Improved Efficiency and Effectiveness of Deceased Organ Donation and Transplantation
Status: RECRUITING
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Every year thousands of Canadians receive life-saving cost-effective organ transplants while thousands more still wait or die because not enough organs are available Patients with non-recoverable illnesses who are undergoing withdrawal of life sustaining measures can donate their organs when they die by a process called donation after circulatory determined death DCD However over 30 of all DCD attempts are unsuccessful because patients do not die within the time frame required for healthy organ retrieval and prolonged exposure to low oxygen during the dying process renders organs unsuitable for transplantation Predicting successful DCD is difficult and leads to uncertainty in the clinical community To address this issue the investigators have developed a clinical decision support tool called Donation Advisor DA that will assist the healthcare team in identifying successful DCD donors and will provide an improved assessment of the health of their organs The investigators are ready to implement DA and evaluate its impact in 7 hospitals in Ontario The investigators believe use of DA will reduce unsuccessful DCD attempts enhance family experience of donation optimize system costs and improve transplant outcomes
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
CTO Project ID 2117 OTHER Clinical Trials Ontario None
1920-HQ-000104 OTHER_GRANT None None
PSI Grant Number 19-33 OTHER_GRANT None None
CRRF 2169 OTHER None None